Tiverton Asset Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Tiverton Asset Management’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-47,517	Closed	-$83K	–	212
2016 Q4	$83K	Sell	47,517 -132,900	-74%	-$271K	﹤0.01%	190
2016 Q3	$487K	Buy	180,417 +121,468	+206%	+$308K	0.04%	152
2016 Q2	$2.55M	Sell	58,949 -439,814	-88%	-$1.21M	0.11%	130
2016 Q1	$1.61M	Sell	498,763 -51,237	-9%	-$189K	0.05%	143
2015 Q4	$2.63M	Hold	550,000	–	–	0.08%	134
2015 Q3	$3.06M	Sell	550,000 -175,000	-24%	-$1.29M	0.07%	139
2015 Q2	$5.77M	Hold	725,000	–	–	0.11%	128
2015 Q1	$7.61M	Buy	725,000 +271,016	+60%	+$3.7M	0.16%	113
2014 Q4	$5.46M	Buy	+453,984	New	+$6.9M	0.11%	113

Other funds holding BDSI

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Tiverton Asset Management's BDSI Position: Q1 2017 in Review

Tiverton Asset Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2017, closing a stake of 47,517 shares — an estimated $83K sold.

Tiverton Asset Management first reported a position in BDSI in Q4 2014 and held it in 9 quarters. The position peaked at $7.61M in Q1 2015. 63 funds tracked by Wall St. Rank hold BDSI as of Q1 2017.

Tiverton Asset Management reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2017 after selling out during the quarter.
Tiverton Asset Management sold 47,517 BioDelivery Sciences International, Inc. shares in Q1 2017, an estimated $83K.
Tiverton Asset Management first reported a position in BioDelivery Sciences International, Inc. in Q4 2014 and held it in 9 quarters.
Tiverton Asset Management's BioDelivery Sciences International, Inc. position peaked at $7.61M in Q1 2015.
63 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2017.

Based on Tiverton Asset Management's 13F filing for Q1 2017, filed 15 May 2017.